Spruce biosciences to participate in the jefferies global healthcare conference

South san francisco, calif.--(business wire)--spruce biosciences, inc. (nasdaq: sprb), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that javier szwarcberg, m.d., m.p.h., chief executive officer, will present at the jefferies global healthcare conference on june 5, 2024, at 5:00 p.m. et. interested parties can access the live webcast here. an archived copy of the.
SPRB Ratings Summary
SPRB Quant Ranking